PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
107.94%
Some net income increase while MRVL is negative at -215.79%. John Neff would see a short-term edge over the struggling competitor.
4.93%
D&A growth well above MRVL's 1.98%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-21.62%
Negative yoy deferred tax while MRVL stands at 97.44%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-0.81%
Both cut yoy SBC, with MRVL at -10.54%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
132.99%
Slight usage while MRVL is negative at -965.08%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
163.66%
AR growth well above MRVL's 295.28%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-25.40%
Both reduce yoy inventory, with MRVL at -117.58%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
78.95%
A yoy AP increase while MRVL is negative at -42.59%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-46.19%
Both reduce yoy usage, with MRVL at -185.43%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
188.24%
Some yoy increase while MRVL is negative at -49.66%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
473.72%
Some CFO growth while MRVL is negative at -14.48%. John Neff would note a short-term liquidity lead over the competitor.
3.96%
Some CapEx rise while MRVL is negative at -17.65%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
3.31%
Purchases growth of 3.31% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-55.17%
We reduce yoy sales while MRVL is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-327.78%
We reduce yoy other investing while MRVL is 122.92%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-100.13%
Both yoy lines negative, with MRVL at -23.70%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
65.19%
Repurchase growth 1.25-1.5x MRVL's 47.20%. Bruce Berkowitz would confirm if the firm invests enough in expansions while boosting EPS.